Cannabiis Use Disorder Market Size in the 7MM is expected to witness a Major Change in the study period 2019-2032, estimates DelveInsight

"The Cannabiis Use Disorder market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Cannabiis Use Disorder pipeline products will significantly revolutionize the Cannabiis Use Disorder market dynamics"

The Cannabiis Use Disorder market report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM Cannabiis Use Disorder market size from 2019 to 2032. The report also covers current Cannabiis Use Disorder treatment practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential.

Key Takeaways from the Cannabiis Use Disorder Market Report
• The increase in Cannabiis Use Disorder market size is a direct consequence of increasing prevalence of Cannabiis Use Disorder (CUD) and the awareness to de-addict the youth, across the 7MM.
• According to DelveInsight's analysis, Cannabiis Use Disorder is more prevalent in males as compared to females.
• The leading Cannabiis Use Disorder Companies working in the market include Indivior, Aelis Farma, PleoPharma Inc., Tilray, Fenix Innovation Group, Neurotech International, BrosMed Medical Co. Ltd., Klein Buendel Inc., and others.
• Promising Cannabiis Use Disorder Pipeline Therapies in the various stages of development include AEF0117, FEN164, Brexpiprazole, MediCabilis Oil, Cannabiidiol Oil Capsules, MediCabilis oil, and others.
• On April 2023, Aelis Farma announced a study of phase 2 clinical trails for AEF0117. The safety and tolerability of AE0117 has been demonstrated in the clinical studies conducted to date. This study will provide additional data on the efficacy of AEF0117 on treatment-seeking subjects with moderate to severe CUD.
• On June 2023, PleoPharma Inc. announced a study of phase 2 clinical trials for Gabapentin and Nabilone. This study will be a randomized, double-blind, placebo-controlled, multicenter trial conducted to evaluate whether PP-01 mitigates the withdrawal symptoms associated with discontinuing Cannabiis in participants with moderate to severe Cannabiis Use Disorder (CUD). The study will enroll approximately 225 participants with moderate to severe CUD and will include 5 arms, including a placebo arm, to help assess the incidence and severity of withdrawal symptoms in heavy long-term users of Cannabiis. Participants receive study medication for 34 days and participate in 11 visits (7 at a clinic and 4 telemedicine).

Discover more about therapies set to grab major Cannabiis Use Disorder Market Share @ Cannabiis Use Disorder Market Size- https://www.delveinsight.com/report-store/Cannabiis-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Cannabiis Use Disorder Overview
Cannabiis (also called marijuana) is the third most commonly used psychoactive substance worldwide, after alcohol and tobacco (nicotine). Cannabiis can be administered by various methods including smoking, vaping, dabbing, ingesting (edibles, beverages, and tinctures), and topical cream. Cannabiis use disorder develops in approximately 10% of regular Cannabiis users and up to 50% of chronic daily users and may be associated with cognitive impairment, poor school or work performance, and psychiatric comorbidity such as mood disorders and psychosis.

Cannabiis Use Disorder Epidemiology Segmentation in the 7MM
• Total Cannabiis Use Disorder Prevalent Cases
• Cannabiis Use Disorder Age-Specific Cases
• Cannabiis Use Disorder Gender-Specific Cases

Download the report to understand which factors are driving Cannabiis Use Disorder Epidemiology Trends @ Cannabiis Use Disorder Epidemiological Insights- https://www.delveinsight.com/sample-request/Cannabiis-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Cannabiis Use Disorder Market Growth
The Market Value of Cannabiis Use Disorder is forecasted to steadily grow from XX in 2019 to XX in 2032. The increasing prevalence of Cannabiis Use Disorder in almost all 7MM, new upcoming novel therapies and regulatory programs to fasten lab-to-market process are projected to propel the market growth during the forecast period.

Cannabiis Use Disorder Market Size
The Cannabiis Use Disorder market size is likely to grow during the forecast period owing to the increasing prevalence of Cannabiis use disorder among youth, boosted by legalization of Cannabiis use in many geographies, steps by governments to stop drug abuse.

To know more about Cannabiis Use Disorder Treatment options, visit @ Cannabiis Use Disorder Drugs- https://www.delveinsight.com/sample-request/Cannabiis-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Cannabiis Use Disorder Market Dynamics
Cannabiis Use Disorder market dynamics is expected to change due to increasing prevalence of Cannabiis Use Disorder leading to the development of novel pharmacologic interventions during the forecast period of 2023─2032. Companies are persistently working towards the development of new treatment therapies and some of the key players at the global level are Indivior, among others.

Cannabiis Use Disorder Market Outlook
The Cannabiis Use Disorder market outlook is a subject of growing importance in the healthcare industry. With the changing legal landscape and increasing acceptance of Cannabiis for medicinal and recreational purposes, concerns about the potential for misuse and addiction have come to the forefront. Cannabiis Use Disorder refers to a pattern of problematic Cannabiis use leading to significant impairment or distress. As the prevalence of Cannabiis use rises, so does the need for effective treatments and interventions for individuals struggling with CUD.

Learn more about the Cannabiis Use Disorder Pipeline Therapies in clinical trials @ Cannabiis Use Disorder Market Landscape- https://www.delveinsight.com/sample-request/Cannabiis-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Cannabiis Use Disorder Pipeline Report
• Coverage- 7MM
• Cannabiis Use Disorder Companies- Indivior, Aelis Farma, PleoPharma Inc., Tilray, Fenix Innovation Group, Neurotech International, BrosMed Medical Co. Ltd., Klein Buendel Inc., and others.
• Cannabiis Use Disorder Pipeline Therapies- AEF0117, FEN164, Brexpiprazole, MediCabilis Oil, Cannabiidiol Oil Capsules, MediCabilis oil, and others.
• Cannabiis Use Disorder Market Dynamics: Cannabiis Use Disorder Market Drivers and Barriers
• Cannabiis Use Disorder Market Access and Reimbursement, Unmet Needs, Analyst Views

Discover more about Cannabiis Use Disorder Drugs in development @ Cannabiis Use Disorder Ongoing Clinical Trials Analysis- https://www.delveinsight.com/sample-request/Cannabiis-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Executive Summary of Cannabiis Use Disorder
3. Competitive Intelligence Analysis for Cannabiis Use Disorder
4. Cannabiis Use Disorder: Market Overview at a Glance
5. Cannabiis Use Disorder: Disease Background and Overview
6. Patient Journey
7. Cannabiis Use Disorder Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Cannabiis Use Disorder Treatment
11. Marketed Products
12. Emerging Therapies
13. Cannabiis Use Disorder: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Cannabiis Use Disorder
17. KOL Views
18. Cannabiis Use Disorder Market Drivers
19. Cannabiis Use Disorder Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Get in touch with our Business executive @ Cannabiis Use Disorder Market Drivers and Barriers- https://www.delveinsight.com/sample-request/Cannabiis-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Important Published Links-

https://treadmill.mn.co/posts/45459156
https://chineseintheus.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast
https://wear.net/dennydones9/
https://productinn.mn.co/posts/parkinsons-disease-market-outlook-and-forecast-report-2032
https://justchatting.mn.co/posts/45460636
https://expressyourcurve.mn.co/posts/45460860
https://clinalleve.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast-2032
https://nhattao.com/members/user6331540.6331540/
https://seedly.sg/profile/denny-dones/
https://note.com/denny_dones/n/n489e5dd1ff1a
https://www.storeboard.com/JohnSmith-5965202
https://doodleordie.com/profile/dennydones99
https://macro.market/company/delveinsight-business-research
https://pantip.com/profile/7306022#topics
https://allmylinks.com/dennydonesusa
https://uconnect.ae/read-blog/4382
https://blacksnetwork.net/post/102497_herpetic-keratitis-is-a-condition-that-affects-the-eye-and-is-caused-by-the-herp.html
https://ekonty.com/-dennydones99
https://app.wedonthavetime.org/posts/03e285b9-e449-4c96-b257-8cb7a2b74243
https://www.weddingbee.com/members/dennydones99/
https://community.storytellingwithdata.com/members/me/gallery
https://participer.valdemarne.fr/profiles/denny_dones/activity
https://elderassociation.mn.co/posts/45117025
https://www.domestika.org/en/dennydones99
https://nxgen.mn.co/members/19995548
https://www.laclt.com/profile/ybhardwaj/profile
https://stemfemmes.mn.co/posts/emerging-trends-in-managing-hot-flashes-in-the-prostate-cancer-market
https://network-91053.mn.co/posts/45119865
https://autism-support.mn.co/posts/understanding-hot-flashes-in-prostate-cancer-market-size-and-outlook-2032
https://jasa-seo.mn.co/posts/45120226
https://lapp.unl.edu.ec/profiles/dennydones99/activity?locale=en
https://imarticus.org/skillenza/user/dennydones9
https://oppathingzz.mn.co/members/20019648
https://findaspring.org/members/dennydones9/
https://www.poeticous.com/yashveer-bhardwaj
https://git.disroot.org/dennydones9
https://kuula.co/profile/havensmith
https://artmight.com/user/profile/3082810
https://www.credly.com/users/denny-dones/badges
https://quantum-buoyancy.mn.co/posts/axillary-hyperhidrosis-market-size-and-outlook-delveinsight
https://freeline.mn.co/posts/45202136
https://3dwarehouse.sketchup.com/user/0e9f9584-794e-4467-ac59-79db9efbadd9/Denny-Dones
https://www.hackster.io/dennydones9
https://letterboxd.com/dennydones9/
https://ko-fi.com/dennydones9
https://wakelet.com/@DennyDones813
https://onedio.com/profil/dennydones9
https://www.lyrics.com/user/349564/dennydones9#google_vignette
https://hypothes.is/users/dennydones9
https://shivambhu-hut.mn.co/posts/exploring-the-axillary-hyperhidrosis-market-innovations-treatments-and-future-prospects
https://zumvu.com/dennydones9/
https://onlyfans.com/dennydones9
https://maker.wiznet.io/dennydones9
https://collab.sundance.org/people/Denny-Dones-1699939772
https://insurtechasia.mn.co/posts/45403575
https://meganto-lottery.mn.co/posts/45403650
https://ylimun.mn.co/posts/45403740
https://network-79379.mn.co/posts/45404061
https://acatpg.mn.co/posts/45404422
https://brooklynneo.mn.co/posts/45404495
https://ucat-bootcamp.mn.co/posts/45404540
https://coding-playground.mn.co/posts/45404600
https://living-word-network.mn.co/posts/45404653

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.